EP3713919
Kristölluð form af N-(4-(4-(sýklóprópýlmetýl)píperasín-1-karbónýl)fenýl)kínólín-8-súlfónamíði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.11.2018EP published:
2.8.2023EP application number:
18821779.8
EP translation filed:
2.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
20.11.2038Expiry date:
20.11.2026Next due date:
30.11.2026
Title in English:
CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL) PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDELanguage of the patent:
English
Timeline
Today
21.11.2018EP application
2.8.2023EP Publication
2.10.2023Translation submitted
15.11.2023Registration published
20.11.2026Expires
Owner
Name:
Agios Pharmaceuticals, Inc.Address:
88 Sidney Street, Cambridge, MA 02139, US
Inventor
Name:
SIZEMORE, Jacob, P.Address:
Shrewsbury MA 01545, US
Name:
GUO, LitingAddress:
Suzhou 215000, CN
Name:
MIRMEHRABI, MahmoudAddress:
Halifax Nova Scotia B3M 4T1, CA
Name:
SU, YeqingAddress:
Halifax Nova Scotia B3L 4R1, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762589822 PDate:
22.11.2017Country:
US
Number:
201862691709 PDate:
29.6.2018Country:
US
Classification
Categories:
C07D 215/36, A61P 7/06, A61K 31/4709
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 7.11.2023
Expires: 20.11.2024
Payer: Árnason Faktor ehf.
Number: 7
Paid: 31.10.2024
Expires: 20.11.2025
Payer: Árnason Faktor ehf.
Number: 8
Paid: 19.11.2025
Expires: 20.11.2026
Payer: Árnason Faktor ehf.